SCHEMBL1272872

SCHEMBL1272872

O=C(O)C(CCSc1ccccn1)N[C@@H](c1ccc(F)cc1)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 1/20 0.46
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
CTSL P07711 4/20 0.41
CTSS P25774 3/20 0.40
CTSB P07858 2/20 0.39
CTSK P43235 2/20 0.39
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
POLB P06746 1/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1272875 1.00 NPC1 (0.46) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL1271775 0.89 RAB9A (0.43) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL1271773 0.89 RAB9A (0.43) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL5393674 0.82 CTSL (0.61) CTSLCTSSCTSBCTSK
SCHEMBL3984755 0.82 CTSL (0.61) CTSLCTSSCTSBCTSK
SCHEMBL3978394 0.82 CTSL (0.61) CTSLCTSSCTSBCTSK
SCHEMBL13726336 0.78 CTSL (0.51) ALDH1A1CTSLCTSSCTSBCTSK
SCHEMBL2376013 0.78 CTSL (0.51) ALDH1A1CTSLCTSSCTSBCTSK
SCHEMBL1271741 0.77 MAPK1 (0.42) RAB9AALDH1A1KMT2ACTSLCTSS
SCHEMBL1271745 0.77 MAPK1 (0.42) RAB9AALDH1A1KMT2ACTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866277-B1 SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2014-06-25 EP disclosed
US-20110281879-A1 SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2011-11-17 US disclosed
US-7893093-B2 Sulfonyl containing compounds as cysteine protease inhibitors VIROBAY, INC. (US) 2011-02-22 US disclosed
US-20080287446-A1 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors QUEST DIAGNOSTICS INVESTMENTS LLC 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281879-A1 SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS CTSS, CTSF, CTSB NPC1 178/4885RAB9A 1299/4885ALDH1A1 2741/4885
US-20080287446-A1 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors CTSS, CTSF, CTSB NPC1 178/4885RAB9A 1299/4885ALDH1A1 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.